Health Trials

The Role of Autoantibodies Against G-protein Coupled Receptors in Obesity

ConditionsObesityObesity & OverweightObesity Type 2 Diabetes MellitusObesity and Obesity-related Medical Conditions
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorClaus Bogh Juhl

About this trial

The purpose of this study is to explore if GPCR-autoantibodies:

1. are pressent in people living with obesity, and are associated with degree of obesity 2. if it is associated with obesity related diseases

Eligibility criteria

Qualifiers

Inhabitant in the Region of Southern Denmark

BMI above 30kg/m2

age between 18 and 60 years.

Disqualifiers

individuals previously treated with GLP-1RA medication for any indication

Individuals who have previously undergone bariatric surgery

Individuals with type 1 diabetes

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

160 Participants
are grouped into 1 trial group

Sponsors and collaborators

Claus Bogh Juhl

Lead sponsor

Esbjerg Hospital - University Hospital of Southern Denmark

Sponsor institution

Source ClinicalTrials.gov